Carboplatin/cytarabine/dexamethasoneAspergillosis and septic shock: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1657卷 / 1期

关键词：

D O I：

10.1007/s40278-017-31911-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：111 / 111

相关论文

共 50 条

[1] Cytarabine/idarubicinPulmonary infection and septic shock: 2 case reports
[J]. Reactions Weekly, 2017, 1667 (1) : 103 - 103
[2] Carboplatin/paclitaxelPerforation of sigmoid colon and septic shock: 2 case reports
[J]. Reactions Weekly, 2018, 1685 (1) : 55 - 55
[3] Carboplatin/paclitaxelPerforation of sigmoid colon and septic shock: 2 case reports
[J]. Reactions Weekly, 2017, 1633 (1) : 170 - 170
[4] InfliximabSepsis and septic shock: 2 case reports
[J]. Reactions Weekly, 2017, 1641 (1) : 143 - 143
[5] Cyclophosphamide/rituximabPancytopenia and septic shock: 2 case reports
[J]. Reactions Weekly, 2021, 1870 (1) : 109 - 109
[6] Cytarabine/dexamethasone/idarubicinPancytopenia and septic shock: case report
[J]. Reactions Weekly, 2017, 1652 (1) : 114 - 114
[7] Carboplatin/melphalan/topotecanAlopecia and anaphylactic shock: 2 case reports
[J]. Reactions Weekly, 2018, 1690 (1) : 57 - 57
[8] AntineoplasticsEncephalopathy, febrile neutropenia and septic shock: 2 case reports
[J]. Reactions Weekly, 2019, 1746 (1) : 31 - 31
[9] AntineoplasticsFebrile neutropenia, septic shock and pneumonia : 2 case reports
[J]. Reactions Weekly, 2020, 1801 (1) : 32 - 32
[10] MelphalanMucositis, septic shock and multiorgan failure: 2 case reports
[J]. Reactions Weekly, 2019, 1775 (1) : 300 - 300

← 1 2 3 4 5 →